Aparicio, J ESHAP is an active regimen for relapsing Hodgkin's disease. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology May 1999 - 593-5 p. digital Publication Type: Clinical Trial; Journal Article ISSN: 0923-7534 Standard No.: 10.1023/a:1026454831340 doi Subjects--Topical Terms: AdolescentAdultAgedAntineoplastic Combined Chemotherapy Protocols--therapeutic useCisplatin--administration & dosageCytarabine--administration & dosageEtoposide--administration & dosageFemaleHodgkin Disease--drug therapyHumansMaleMethylprednisolone--administration & dosageMiddle AgedProspective Studies